Lanreotide Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 60 mg, 90 mg, 120 mg
Reference Brands: omatuline Depot (USA), Somatuline Autogel (USA)
Category:
Oncology Cancer Care
Lanreotide is a synthetic octapeptide analogue of somatostatin. It binds to somatostatin receptors (SSTR‑2 and SSTR‑5), inhibiting secretion of growth hormone and other hormones. It is used to treat Acromegaly when surgery/radiotherapy are not suitable and to manage certain neuroendocrine tumours, including gastrointestinal/pancreatic NETs and symptoms of Carcinoid syndrome.
Lanreotide is available in Injection
and strengths such as 60 mg, 90 mg, 120 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lanreotide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lanreotide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing